Health Condition 1: K649- Unspecified hemorrhoids
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients having Arsha who are fulfilling my study criteria and who are willing to be selected will be enrolled Patients with 1st and 2nd degree haemorrhoids Patient of the age group above 30 years below 60 years Patient will be selected irrespective of sex Patients who will be ready to give written consent
Exclusion criteria
Exclusion criteria: Patients planning to conceive in near future[during course of trial] Any congenital diseases like haemophillia Patients with 3 degree, 4 degree or prolapsed piles Pregnant women and Lactating mothers Patients suffering from Thrombosed Piles mass,Ulcerative Colitis and CA rectum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in size of pile massTimepoint: 21 days or 3 week The trial drug will be given for 3 weeks and follow up will be done after 3rd week | — |
Secondary
| Measure | Time frame |
|---|---|
| Bleeding reduced per rectum and relief in burning sensationTimepoint: After analysing all the parameters the result will be assessed on the basis of symptomatic relief and improvement. Partially improvement after 7 days patient gets 30 percent relief from sign and symptoms Improvement after 14 days patient gets 50-60 percent relief from sign and symptoms Cured after 21 days patient gets 80-100 percent relief from sign and symptoms. | — |
Countries
India
Contacts
Vaidya yagya dutt sharma Ayurved Mahavidyalaya Khurja Bulandshahr